Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (91-100 of 292) with videos related to

Pageof 30
Sort By:
Pathology|July 10, 2012
Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancerSarah Minner, Colin De Silva, Michael Rink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2010
BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral bloodNatalia Bednarz, Elke Eltze, Axel Semjonow, et al.
BJU International|September 11, 2022
Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomyMarkus von Deimling, Michael Rink, Jakob Klemm, et al.
Pathology|May 5, 2010
Y chromosome loss is a frequent early event in urothelial bladder cancerSarah Minner, Adisa Kilgué, Phillip Stahl, et al.
Turkish Journal of Urology|October 14, 2020
Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinomaVictor M Schuettfort, Benjamin Pradere, Fahad Quhal, et al.
World Journal of Urology|December 22, 2014
βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinomaAlexander Quaas, Amir-Hossein Rahvar, Christoph Burdelski, et al.
World Journal of Urology|January 12, 2017
Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive reviewAtiqullah Aziz, Jakub Dobruch, Kees Hendricksen, et al.
Urologic Oncology|December 4, 2014
Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy?Armin Soave, Selina Schmidt, Roland Dahlem, et al.
Urologic Oncology|December 25, 2018
Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancerShoji Kimura, David D' Andrea, Francesco Soria, et al.
World Journal of Urology|September 30, 2020
Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysisVictor M Schuettfort, Benjamin Pradere, Fahad Quhal, et al.
Pageof 30

Showing results (91-100 of 292) with videos related to

Sort By:
Pageof 30
Pathology|July 10, 2012
Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancerSarah Minner, Colin De Silva, Michael Rink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2010
BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral bloodNatalia Bednarz, Elke Eltze, Axel Semjonow, et al.
BJU International|September 11, 2022
Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomyMarkus von Deimling, Michael Rink, Jakob Klemm, et al.
Pathology|May 5, 2010
Y chromosome loss is a frequent early event in urothelial bladder cancerSarah Minner, Adisa Kilgué, Phillip Stahl, et al.
Turkish Journal of Urology|October 14, 2020
Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinomaVictor M Schuettfort, Benjamin Pradere, Fahad Quhal, et al.
World Journal of Urology|December 22, 2014
βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinomaAlexander Quaas, Amir-Hossein Rahvar, Christoph Burdelski, et al.
World Journal of Urology|January 12, 2017
Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive reviewAtiqullah Aziz, Jakub Dobruch, Kees Hendricksen, et al.
Urologic Oncology|December 4, 2014
Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy?Armin Soave, Selina Schmidt, Roland Dahlem, et al.
Urologic Oncology|December 25, 2018
Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancerShoji Kimura, David D' Andrea, Francesco Soria, et al.
World Journal of Urology|September 30, 2020
Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysisVictor M Schuettfort, Benjamin Pradere, Fahad Quhal, et al.
Pageof 30